A novel explainable AI model accurately detects and localizes breast tumors on MRI, outperforming conventional models—especially in low-cancer-prevalence screening scenarios.
Key Details
- 1The explainable fully convolutional data description (FCDD) model was trained and tested on 9,738 breast MRI exams from 2005-2022, plus an external multicenter dataset.
- 2FCCD outperformed standard binary classification models, achieving AUCs up to 0.84 (balanced tasks) and 0.72 (imbalanced) vs. 0.81 and 0.69 for benchmarks (p<0.001).
- 3In internal and external validation, FCCD consistently showed higher detection performance, e.g., AUC of 0.86 vs. 0.79 (external set).
- 4The model achieved a specificity of 13% vs. 9% for the benchmark at 97% sensitivity in imbalanced (realistic) settings (p=0.02).
- 5It produces interpretable heatmaps to highlight probable tumor areas, addressing the 'black box' issue in AI models.
- 6Researchers note potential to streamline breast MRI screening, including use with abbreviated MRI protocols.
Why It Matters
Demonstrating robust detection of breast cancer in both high and low prevalence MRI datasets, this explainable AI system advances the field toward more transparent, generalizable tools for radiologists. Its validated, interpretable outputs may enhance clinical adoption and trust in AI-based breast imaging solutions.
Source
AuntMinnie
Related News
•Radiology Business
Rayus Radiology Launches $40 AI Mammography Screenings in Washington
Rayus Radiology is introducing a $40 AI-enhanced mammography add-on service at clinics in Washington state.
•AuntMinnie
AI Tool Mirai Shows Robust Performance for Interval Breast Cancer Detection
The Mirai AI model significantly improves detection of interval breast cancers in negative screening mammograms.
•Radiology Business
AI Tool Predicts Interval Breast Cancer Risk from Negative Mammograms
AI can predict interval breast cancer risk up to three years after a negative mammogram.